Displaying 1–25 of 10631 results for

Sort By Relevance Sort By Date
1 2 3 4 5 ...426

Gilead partners with insitro for experimental liver meds

(News)

Gilead is paying insitro $15 million upfront with additional near-term payments up to $35 million based on operational milestones.

Biden says gov't failed to deal with opioid crisis

(News)

Joe Biden addressed a sold-out audience at University of Pennsylvania, joining a panel conversation about the opioid crisis.

BMS shareholders approve Celgene megadeal

(News)

Bristol-Myers Squibb shareholders approved the company’s $74 billion acquisition of rival Celgene, despite activist campaigns to break up the deal.

New look, same great taste

(Article)

FDA loosens booze ban for Sprout libido drug

(News)

The US FDA announced that women taking Sprout Pharma's female libido pill, Addyi, do not need to completely avoid alcohol.

Pharma finds balance

(Article)

Despite negative public opinions and heavy demands, survey respondents indicate rising satisfaction and pride in their work

Amgen wins approval for osteoporosis drug — but with strict warnings

(News)

The FDA has greenlighted Amgen’s new osteoporosis drug for postmenopausal women

DOJ charges UK drugmaker with Suboxone fraud

(News)

Federal prosecutors with the Department of Justice have indicted Indivior for what they call a multibillion-dollar scheme to ratchet up sales of an opioid addiction treatment.

FDA refuses Zogenix seizure drug

(News)

The U.S. Food and Drug Administration, after a preliminary review, cited a lack of certain non-clinical studies to assess the chronic administration of fenfluramine and due to an incorrect dataset.

ViiV two-drug HIV combo wins U.S approval

(News)

ViiV is GSK’s HIV drugs division where Pfizer and Shionogi & Co have stakes as well.

Creating a Pharma Packaging Line That Fits Acidic Products

(Article)

Acidic liquids could cause damage to equipment over time through corrosion, which will result in costly breakdowns and downtime without sufficient preventive measures.

Celgene files BLA for blood disease drug

(News)

Celgene and Acceleron Pharma announced that Celgene has submitted a Biologics License Application (BLA) for one of the drugmaker's most promising experimental blood disease drugs.

Apotex reportedly looking at sale as investigation of CEO death continues

(News)

Nearly a year and a half after the death of Apotex’s founder and CEO and his wife, the company is reportedly mulling a sale.

Regeneron buddies up with Alnylam to develop therapies with Nobel-winning tech

(News)

Regeneron Pharmaceuticals is investing $800 million into a deal with Alnylam Pharmaceuticals to make treatments using an innovative gene-silencing approach.

United Therapeutics abandons PAH trial

(News)

United Therapeutics has halted a late stage trial for its pulmonary arterial hypertension candidate after the drug failed to achieve the study's primary endpoint.

Merrimack axes tumor treatment trial

(News)

Merrimack Pharmaceuticals, an oncology company focused on biomarker-defined cancers, announced that it is abandoning its experimental drug, MM-310, after an early-stage trial involving patients with solid tumors showed that treatment with the drug was cumulatively toxic to patient

Amgen-Novartis migraine collab goes sour

(News)

Amgen’s multibillion-dollar collaboration with Novartis to jointly develop and market Amgen’s migraine-prevention treatment has resulted in both companies filing lawsuits.

AstraZeneca, Daiichi Sankyo partner on cancer ADC

(News)

AstraZeneca has entered into an agreement with Japanese-based Daiichi Sankyo to develop and commercialize trastuzumab deruxtecan, a proprietary antibody-drug conjugate (ADC) and potential new targeted medicine for cancer treatment.

Drowning in Data?

(Article)

Follow these five steps to quench your thirst for insights from your data.

Novo Nordisk puts $100 million into production upgrades and expansions

(News)

The facilities in Kalundborg, Denmark, will be rebuilt to allow for production beyond diabetes treatments.

Roche extends $4.3 million offer for Spark Therapeutics

(News)

Roche, which is looking to expand in gene therapy, will extend its original deadline a month until May 2.

Novartis subsidiary AveXis buys AstraZeneca site in Colorado

(News)

The company plans to rehire all the former AstraZeneca employees to work in the 700,000-square-foot, six-building campus.

Purdue owners request Massachusetts opioid case to be thrown out

(News)

The Sackler family are arguing that the lawsuit from the Massachusetts attorney general is misleading.

The Human-Machine Matchup

(Article)

Combining human reasoning with the machine learning functionality found in advanced analytics applications improves pharma processes

Heritage Pharma files lawsuit after drug shipment knocked into a river

(News)

New Jersey-based Heritage Pharmaceuticals is seeking damages from a Port of Virginia blunder that sent a container of its drugs toppling into the Elizabeth River.

Sort By Relevance Sort By Date
1 2 3 4 5 ...426